Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Sylvie van der Werf and Vincent Enouf.
Connection Strength

1.319
  1. A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations. Sci Transl Med. 2020 09 02; 12(559).
    View in: PubMed
    Score: 0.224
  2. Seasonal Genetic Drift of Human Influenza A Virus Quasispecies Revealed by Deep Sequencing. Front Microbiol. 2018; 9:2596.
    View in: PubMed
    Score: 0.198
  3. Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France. Lancet Reg Health Eur. 2021 Sep; 8:100171.
    View in: PubMed
    Score: 0.060
  4. Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020. Euro Surveill. 2021 04; 26(13).
    View in: PubMed
    Score: 0.059
  5. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. Nat Med. 2021 05; 27(5):917-924.
    View in: PubMed
    Score: 0.059
  6. SARS-CoV-2 viral dynamics in non-human primates. PLoS Comput Biol. 2021 03; 17(3):e1008785.
    View in: PubMed
    Score: 0.058
  7. Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021. Euro Surveill. 2021 03; 26(9).
    View in: PubMed
    Score: 0.058
  8. Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification. PLoS One. 2021; 16(1):e0243712.
    View in: PubMed
    Score: 0.058
  9. Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus. One Health. 2020 Dec; 10:100164.
    View in: PubMed
    Score: 0.056
  10. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature. 2020 09; 585(7826):584-587.
    View in: PubMed
    Score: 0.056
  11. Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020. Euro Surveill. 2020 07; 25(26).
    View in: PubMed
    Score: 0.056
  12. Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination. Emerg Infect Dis. 2020 08; 26(8):1944-1946.
    View in: PubMed
    Score: 0.055
  13. Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020. Euro Surveill. 2020 04; 25(14).
    View in: PubMed
    Score: 0.055
  14. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 06; 20(6):697-706.
    View in: PubMed
    Score: 0.055
  15. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill. 2020 03; 25(9).
    View in: PubMed
    Score: 0.054
  16. Epidemiological Risk Factors for Animal Influenza A Viruses Overcoming Species Barriers. Ecohealth. 2017 06; 14(2):342-360.
    View in: PubMed
    Score: 0.045
  17. Performance of influenza case definitions for influenza community surveillance: based on the French influenza surveillance network GROG, 2009-2014. Euro Surveill. 2017 Apr 06; 22(14).
    View in: PubMed
    Score: 0.044
  18. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis. 2014 Jan; 14(1):50-56.
    View in: PubMed
    Score: 0.035
  19. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet. 2013 Jun 29; 381(9885):2265-72.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.